News
11-10-2010, 10:02 PM
Generex Biotechnology Corporationannounced today that its wholly-owned immunotherapeutics subsidiary, Antigen Express, Inc. has been awarded two Therapeutic Discovery Project grants, totaling $488,958.50, by the United States Internal Revenue Service (IRS) and the Department of Health and Human Services (HHS) pursuant to the Patient Protection and Affordable Care Act of 2010.
More... (http://www.news-medical.net/news/20101110/Antigen-Express-awarded-Therapeutic-Discovery-Project-grants-for-cancer-vaccine-development.aspx)
More... (http://www.news-medical.net/news/20101110/Antigen-Express-awarded-Therapeutic-Discovery-Project-grants-for-cancer-vaccine-development.aspx)